Biosensors BioMatrix Alpha Drug Eluting Coronary Stent System - HSA Registration DE0018565
Access comprehensive regulatory information for Biosensors BioMatrix Alpha Drug Eluting Coronary Stent System in the Singapore medical device market through Pure Global AI's free database. This CLASS COM medical device is registered under HSA registration number DE0018565 and owned by Biosensors Europe SA. The device was registered on September 20, 2016.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The BioMatrix Alpha stent is indicated for improving coronary luminal diameter for the treatment of de novo lesions in native coronary arteries with a reference diameter ranging between 2.25mm and 4.0mm. Stents with lengths 33 and 36mm are only available for artery diameters ranging between 2.5 mm and 3.5 mm.